https://scdstudies.com/a-phase-1-2-open-label-dose-escalating-study-evaluating-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-ab1-in-adult-patients-with-sickle-cell-disease-scd/?utm_source=rss&utm_medium=rss&utm_campaign=a-phase-1-2-open-label-dose-escalating-study-evaluating-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-ab1-in-adult-patients-with-sickle-cell-disease-scd Thu, 13 Jun 2024 12:24:17 +0000 hourly 1 https://wordpress.org/?v=6.7.1